Regeneron Pharmaceuticals | REGN - Pendapatan Penjualan





Penjualan Perubahan Tanggal
AbbVie USD 15B 1.62B 2026-03
Agenus USD 34.2M 3.97M 2025-12
Agios Pharmaceuticals USD 18.8M 1.17M 2026-03
Alnylam Pharmaceuticals USD 1.17B 70M 2026-03
Amgen USD 8.62B 1.28B 2026-03
Astellas Pharma JPY 537.93B 33.28B 2026-03
AstraZeneca USD 15.29B 213M 2026-03
Biogen USD 2.25B 30M 2026-03
BioMarin Pharmaceutical USD 766M 109M 2026-03
Bristol-Myers Squibb USD 11.49B 1.01B 2026-03
Eli Lilly USD 19.8B 500M 2026-03
Esperion Therapeutics USD 168.45M 81.14M 2025-12
Gilead Sciences USD 7B 930M 2026-03
GlaxoSmithKline GBP 7.63B 991M 2026-03
Incyte USD 1.27B 240M 2026-03
Ionis Pharmaceuticals USD 246M 43M 2026-03
J&J USD 24.1B 500M 2026-03
Kyowa Hakko Kirin JPY 118.47B 28.91B 2026-03
Merck USD 16.29B 110M 2026-03
Moderna USD 389M 289M 2026-03
Neurocrine Biosciences USD 811M 5.5M 2026-03
Novartis USD 13.11B 226M 2026-03
Novartis USD 13.11B 750M 2026-03
Pfizer USD 14.5B 3.08B 2026-03
Puma Biotechnology USD 80.54M 33.46M 2024-09
Regeneron Pharmaceuticals USD 3.6B 280M 2026-03
Roche Holding CHF 15.65B 274.5M 2025-12
Sanofi EUR 12.14B 65M 2026-03
Sarepta Therapeutics USD 730.8M 287.9M 2026-03
Teva Pharmaceutical Industries USD 11.77B 2.86B 2026-03
Ultragenyx Pharmaceutical USD 136M 71M 2026-03
United Therapeutics USD 781.5M 8.7M 2026-03
Vertex Pharmaceuticals USD 2.99B 200M 2026-03